Earnings Feed
Start Free
TENAX THERAPEUTICS, INC.·4

Jan 13, 8:29 PM ET

Almenoff June Sherie 4

4 · TENAX THERAPEUTICS, INC. · Filed Jan 13, 2026

Insider Transaction Report

Form 4
Period: 2026-01-09
TENAX THERAPEUTICS, INC.TENX
Almenoff June Sherie
Director
Transactions
  • Award

    Stock Option (right to buy)

    2026-01-09+30,000→ 30,000 total
    Exercise: $13.30From: 2027-01-09Exp: 2036-01-09→ Common Stock (30,000 underlying)
Holdings

  • Common Stock

    [F1]
    (indirect: By LLC)
    1,993

  • Stock Option (right to buy)

    Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying)
    4

  • Stock Option (right to buy)

    Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying)
    4

  • Stock Option (right to buy)

    Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $5.75From: 2026-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying)
    80,000
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact|2026-01-13

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT